CUSIP: 89853L104
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
20,558,927
-
Share change
-
-311,317
-
Total reported value
-
$108,140,050
-
Put/Call ratio
-
103%
-
Price per share
-
$5.26
-
Number of holders
-
51
-
Value change
-
-$1,766,947
-
Number of buys
-
25
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP 89853L104:
Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q4 2016
As of 31 Dec 2016,
T2 BIOSYSTEMS INC - COM (TTOO) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,558,927 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, Aisling Capital LLC, Senvest Management, LLC, Flagship Pioneering Inc., Polaris Venture Management Co. V, L.L.C., Lagoda Investment Management, L.P., WELLINGTON MANAGEMENT GROUP LLP, TIGER MANAGEMENT L.L.C., VANGUARD GROUP INC, and BlackRock Fund Advisors.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.